Company Overview of Atherogenics Inc.
On June 22, 2009, Atherogenics Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. AtheroGenics, Inc. focuses on the discovery, development, and commercialization of novel therapeutics for the treatment of chronic inflammatory diseases, including diabetes and coronary heart diseases. The company was founded 1993 and is based in Alpharetta, Georgia.
8995 Westside Parkway
Alpharetta, GA 30009
Founded in 1993
Key Executives for Atherogenics Inc.
Atherogenics Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Somanta Pharmaceuticals, Inc.||United States|
|York Pharmaceuticals, Inc.||United States|
|Cellular Engineering Technologies Inc.||United States|
|Metronome Therapeutics Inc.||United States|
|Pfizer Centre Source||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- East Township, NY | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Princeton, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Atherogenics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.